Contraline, a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective male contraception, has appointed medical device industry executive Martin Emerson to its Board of Directors. “Marty joins our Board at an exciting time as we transition to a clinical-stage organization and plan to initiate our first-in-human clinical trial of ADAM, the world’s first injectable hydrogel…
INVO Bioscience, a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, is pleased to announce the appointment of tenured women’s health & fertility solution marketing professional, Meryle Lynn Chamberlain, as Director of Marketing, a newly created position within the company. Chamberlain brings over 15 years of…
ObsEva, a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced the appointment of Clive Bertram as Chief Commercial Officer and member of ObsEva’s Executive Committee, effective May 10, 2021. Wim Souverijns has served as Chief Commercial Officer of ObsEva since November 2018 and will leave the Company on June 30, 2021 to pursue a new opportunity.…
Kindbody today announced Meredith Whitney as its Chief Financial Officer and newest addition to its female-led executive team. Whitney joins Kindbody as a seasoned leader with a long and illustrious career in finance, having shattered the glass ceiling during her time on Wall Street. Whitney has been one of the most visible female analysts on Wall Street, earning recognition from Fortune Magazine as one…
Daré Bioscience, a leader in women’s health innovation, today announced the appointment of Sophia N. Ononye-Onyia, PhD MPH MBA to its Board of Directors. Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve…
Bonafide, the company pioneering mainstream medical use of drug-free, naturally derived health solutions for menopause, announces today that Dr. Alyssa Dweck will join its team as its Chief Medical Officer. Bonafide’s products are already trusted by over 9,000 unpaid health care professionals, primarily OBGYNs, and more than 70,000 women. The addition of Dr. Dweck to Bonafide’s leadership team is in alignment with…
Women’s health biotech Celmatix focused uniquely on ovarian biology, today announced that Dr. Adrienne Day has joined the company’s advisory board. Dr. Day joins as the company eyes upcoming nonclinical studies for the lead RSTK agonist program, and continued partnering interest in its category-defining multi-omic ovarian health platform. She will play a key role in supporting the strategic and scientific prioritization of…
Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Susan Stimson has been appointed as an independent member to the company’s Board of Directors. Ms. Stimson joins the Gynesonics’ Board with more than 25 years of experience in the development and commercialization of high-impact medical devices. She currently…
